FR0000120578
© Globe Newswire
27.05.2025
SAN
LISTED
EURONEXT
Press Release: Sanofi completes acquisition of DR-0201
News Preview
Sanofi completes acquisition of DR-0201...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.05.2025
SAN
LISTED
EURONEXT
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
News Preview
Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.05.2025
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares - April 2025
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
02.05.2025
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares - March 2025
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
30.04.2025
SAN
LISTED
EURONEXT
Press Release: Annual General Meeting of April 30, 2025
News Preview
Annual General Meeting of April 30, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.04.2025
SAN
LISTED
EURONEXT
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
News Preview
Sanofi and CD&R close Opella transaction, create global consumer healthcare leader...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.04.2025
SAN
LISTED
EURONEXT
Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race
News Preview
When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.04.2025
SAN
LISTED
EURONEXT
Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race
News Preview
When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.04.2025
SAN
LISTED
EURONEXT
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
News Preview
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.04.2025
SAN
LISTED
EURONEXT
Communiqué de presse - Sanofi inaugure en France sa nouvelle unité d’excellence R&D Vaccins
News Preview
Sanofi inaugure en France sa nouvelle unité d’excellence R&D Vaccins...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.04.2025
SAN
LISTED
EURONEXT
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
News Preview
Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.04.2025
SAN
LISTED
EURONEXT
Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
News Preview
Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
03.04.2025
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares - February 2025
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.04.2025
SAN
LISTED
EURONEXT
Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
News Preview
Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.03.2025
SAN
LISTED
EURONEXT
Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors
News Preview
Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.03.2025
SAN
LISTED
EURONEXT
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.03.2025
SAN
LISTED
EURONEXT
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
News Preview
Chlamydia vaccine candidate granted fast track designation by the US FDA...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.03.2025
SAN
LISTED
EURONEXT
Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
News Preview
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.03.2025
SAN
LISTED
EURONEXT
Press Release: Availability of the Q1 2025 Aide mémoire
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.03.2025
SAN
LISTED
EURONEXT
Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
News Preview
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.03.2025
SAN
LISTED
EURONEXT
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
News Preview
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.03.2025
SAN
LISTED
EURONEXT
Press release: Sanofi successfully prices EUR 1.5 billion of bond issue
News Preview
Sanofi successfully prices EUR 1.5 billion of bond issue ...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.02.2025
SAN
LISTED
EURONEXT
Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
News Preview
Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma ...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.02.2025
SAN
LISTED
EURONEXT
Communiqué de presse : Sanofi lance la tournée de Zeus, le cheval métallique de la cérémonie d’ouverture
News Preview
Sanofi lance la tournée de Zeus, le cheval métallique de la cérémonie d’ouverture...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.02.2025
SAN
LISTED
EURONEXT
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
News Preview
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.02.2025
SAN
LISTED
EURONEXT
Press Release: Sanofi and CD&R sign Opella share purchase agreement
News Preview
Sanofi and CD&R sign Opella share purchase agreement...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.02.2025
SAN
LISTED
EURONEXT
Press Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid
News Preview
Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.02.2025
SAN
LISTED
EURONEXT
Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.02.2025
SAN
LISTED
EURONEXT
Press Release: Execution of a share buyback agreement for up to €2 billion
News Preview
Execution of a share buyback agreement for up to €2 billion...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.01.2025
SAN
LISTED
EURONEXT
Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant
News Preview
Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant ...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.01.2025
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares - December 2024
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.01.2025
SAN
LISTED
EURONEXT
Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma
News Preview
Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2025
SAN
LISTED
EURONEXT
Press Release: Opella reaches study milestone for Cialis
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2025
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares – November 2024
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) ...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2025
SAN
LISTED
EURONEXT
Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma
News Preview
Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2025
SAN
LISTED
EURONEXT
Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma
News Preview
New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.12.2024
SAN
LISTED
EURONEXT
Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines
News Preview
Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.12.2024
SAN
LISTED
EURONEXT
Presse release: Jean-Paul Kress to join Sanofi's Board of Directors
News Preview
Jean-Paul Kress to join Sanofi's Board of Directors...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.12.2024
SAN
LISTED
EURONEXT
Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis
News Preview
Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.12.2024
SAN
LISTED
EURONEXT
Press Release: Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US
News Preview
Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.12.2024
SAN
LISTED
EURONEXT
Press Release: ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients
News Preview
ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.12.2024
SAN
LISTED
EURONEXT
Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP
News Preview
ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.12.2024
SAN
LISTED
EURONEXT
Press Release: Availability of the revised financial statements for Sanofi excluding Opella
News Preview
Availability of the revised financial statements for Sanofi excluding Opella...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2024
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares - October 2024
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.11.2024
SAN
LISTED
EURONEXT
Communiqué de presse - Sanofi renforce la bioproduction d’anticorps en France avec un investissement de plus de 40 millions d’euros sur son site de Lyon Gerland
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.11.2024
SAN
LISTED
EURONEXT
Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
News Preview
Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2024
SAN
LISTED
EURONEXT
Communiqué de presse - Aadil BEZZA rejoint Sanofi comme Directeur des Ressources Humaines France
News Preview
Aadil BEZZA rejoint Sanofi comme Directeur des Ressources Humaines France...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2024
SAN
LISTED
EURONEXT
Communiqué de presse : Sanofi, CEMKA, Lifen et la SFGM-TC s'unissent pour apporter une meilleure compréhension du parcours de soins des patients français souffrant de la maladie du greffon contre l’hôte chronique
News Preview
Sanofi, CEMKA, Lifen et la SFGM-TC s'unissent pour apporter une meilleure compréhension du parcours de soins des patients français souffrant de la maladie du greffon contre l’hôte chronique...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2024
SAN
LISTED
EURONEXT
Press Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis
News Preview
Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2024
SAN
LISTED
EURONEXT
Communiqué de presse - Sanofi obtient l’Autorisation de Mise sur le Marché d’Efluelda, son vaccin trivalent haute dose, pour la prochaine saison grippe 2025/2026
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2024
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares - September 2024
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.10.2024
SAN
LISTED
EURONEXT
Communiqué de presse : Sanofi en discussions pour céder une participation majoritaire dans Opella
News Preview
Sanofi en discussions pour céder une participation majoritaire dans Opella...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.10.2024
SAN
LISTED
EURONEXT
Press Release: Sanofi in discussions to sell a controlling stake in Opella
News Preview
Sanofi in discussions to sell a controlling stake in Opella...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2024
SAN
LISTED
EURONEXT
Press Release: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.09.2024
SAN
LISTED
EURONEXT
Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.09.2024
SAN
LISTED
EURONEXT
Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD
News Preview
Dupixent approved in China as the first-ever biologic medicine for patients with COPD...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2024
SAN
LISTED
EURONEXT
Press Release: Availability of the Q3 2024 Aide mémoire
News Preview
Availability of the Q3 2024 Aide mémoire...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2024
SAN
LISTED
EURONEXT
Communiqué de presse France : Sanofi devient membre fondateur de la Fondation de l’Université Paris-Saclay et apporte son soutien financier dans le cadre d’une convention de mécénat
News Preview
Sanofi devient membre fondateur de la Fondation de l’Université Paris-Saclay et apporte son soutien financier dans le cadre d’une convention de mécénat...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.09.2024
SAN
LISTED
EURONEXT
Press Release: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant
News Preview
Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant ...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.09.2024
SAN
LISTED
EURONEXT
Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
News Preview
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
